These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8541725)

  • 21. Immunohistochemical expression of BCL-2 in melanomas and intradermal nevi.
    Saenz-Santamaría MC; Reed JA; McNutt NS; Shea CR
    J Cutan Pathol; 1994 Oct; 21(5):393-7. PubMed ID: 7868749
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Contribution of monoclonal antibody HMB45 in the histopathologic diagnosis of melanoma].
    Pluot M; Joundi A; Grosshans E
    Ann Dermatol Venereol; 1990; 117(10):691-9. PubMed ID: 1705764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Malignant melanoma within an intradermal nevus.
    Tajima Y; Nakajima T; Sugano I; Nagao K; Kondo Y
    Am J Dermatopathol; 1994 Jun; 16(3):301-6. PubMed ID: 7943639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acral lentiginous melanoma (including in situ melanoma) arising in association with naevocellular naevi.
    Wong TY; Ohara K; Kawashima M; Sober AJ; Nogita T; Mihm MC
    Melanoma Res; 1996 Jun; 6(3):241-6. PubMed ID: 8819127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increase in telomerase activity during progression of melanocytic cells from melanocytic naevi to malignant melanomas.
    Glaessl A; Bosserhoff AK; Buettner R; Hohenleutner U; Landthaler M; Stolz W
    Arch Dermatol Res; 1999; 291(2-3):81-7. PubMed ID: 10195394
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Nevus associated malignant melanomas--diagnostic validation and prognosis].
    Stadler R; Garbe C
    Hautarzt; 1991 Jul; 42(7):424-9. PubMed ID: 1938395
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Can HLA-DR expression help in the routine diagnosis of malignant melanomas?
    West KP; Priyakumar P; Jagjivan R; Colloby PS
    Br J Dermatol; 1989 Aug; 121(2):175-8. PubMed ID: 2775642
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acral-lentiginous naevus of plantar skin.
    Clemente C; Zurrida S; Bartoli C; Bono A; Collini P; Rilke F
    Histopathology; 1995 Dec; 27(6):549-55. PubMed ID: 8838335
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A distinctive melanocytic lesion associated with melanoma-prone dysplastic naevus syndrome: the hybrid naevus.
    Schubert C; Parwaresch R; Rudolph P
    Virchows Arch; 2001 Feb; 438(2):166-72. PubMed ID: 11253119
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparative study of proliferation indices and ploidy in dysplastic naevi and malignant melanomas using flow cytometry.
    Slater SD; Cook MG; Fisher C; Wright NA; Foster CS
    Histopathology; 1991 Oct; 19(4):337-44. PubMed ID: 1937413
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dermoscopic patterns of intradermal naevi.
    Greco V; Cappello M; Megna M; Costa C; Villani A; Fabbrocini G; Marino V; Scalvenzi M
    Australas J Dermatol; 2020 Nov; 61(4):337-341. PubMed ID: 32715462
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adhesion molecule profile and malignancy of melanocytic lesions.
    Moretti S; Martini L; Berti E; Pinzi C; Giannotti B
    Melanoma Res; 1993 Aug; 3(4):235-9. PubMed ID: 8219755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proliferation marker Ki-S5 as a diagnostic tool in melanocytic lesions.
    Rudolph P; Schubert C; Schubert B; Parwaresch R
    J Am Acad Dermatol; 1997 Aug; 37(2 Pt 1):169-78. PubMed ID: 9270500
    [TBL] [Abstract][Full Text] [Related]  

  • 34. c-KIT receptor expression in cutaneous malignant melanoma and benign melanotic naevi.
    Ohashi A; Funasaka Y; Ueda M; Ichihashi M
    Melanoma Res; 1996 Feb; 6(1):25-30. PubMed ID: 8640066
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Growth dynamics of acquired melanocytic nevi. Higher reactivity of proliferating cell nuclear antigen in junctional and compound nevi than intradermal nevi.
    Tokuda Y; Saida T; Mukai K; Takasaki Y
    J Am Acad Dermatol; 1994 Aug; 31(2 Pt 1):220-4. PubMed ID: 7913717
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determination of proliferating fractions in malignant melanomas by anti-PCNA/cyclin monoclonal antibody.
    Takahashi H; Strutton GM; Parsons PG
    Histopathology; 1991 Mar; 18(3):221-7. PubMed ID: 1675189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Nevus on nevus. Apropos of 7 case reports, 3 of them associated with other dysplasias, and 1 with an invasive malignant melanoma].
    Brufau C; Moran M; Armijo M
    Ann Dermatol Venereol; 1986; 113(5):409-18. PubMed ID: 3579111
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The value of cyclooxygenase-2 expression in differentiating between early melanomas and histopathologically difficult types of benign human skin lesions.
    Kuźbicki Ł; Lange D; Strączyńska-Niemiec A; Chwirot BW
    Melanoma Res; 2012 Feb; 22(1):70-6. PubMed ID: 22228276
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Naevus-associated melanomas: cause or chance?
    Massi D; Carli P; Franchi A; Santucci M
    Melanoma Res; 1999 Feb; 9(1):85-91. PubMed ID: 10338338
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ocular pigmented findings in patients with dysplastic naevus syndrome.
    Toth-Molnar E; Olah J; Dobozy A; Hammer H
    Melanoma Res; 2004 Feb; 14(1):43-7. PubMed ID: 15091193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.